DEA assigns Schedule V status to cannabis-based Epidiolex!
Here’s an update everybody into the medical cannabis community happens to be awaiting: the U.S. Drug Enforcement Administration has offered Today cannabis-derived drug Epidiolex a Schedule V classification.
This is basically the time that is first cannabis-based medication happens to be rescheduled in the usa.
What exactly is Epidiolex, precisely?
Epidiolex can be a prescription that is oral manufactured by U.K.-based GW Pharmaceuticals PLC. It had been formulated to deal with two…